主要收入构成
报告期:2021-12-31
主营产品构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
其他(补充) |
3.01% |
83.20 |
77.62% |
54.89 |
34.03% |
-31.05% |
其他贸易 |
1.08% |
29.81 |
100.66% |
23.13 |
22.42% |
1.76% |
医药批发 |
11.33% |
313.20 |
-24.45% |
294.75 |
5.89% |
-1.24% |
医药生产-儿科类 |
20.54% |
567.80 |
63.66% |
85.20 |
84.99% |
2.28% |
医药生产-妇科类 |
0.29% |
8.14 |
101.16% |
5.65 |
30.64% |
23.65% |
医药生产-精神神经类 |
11.89% |
328.62 |
-27.60% |
44.02 |
86.60% |
-3.90% |
医药生产-抗感染类 |
0.98% |
27.07 |
10.00% |
15.74 |
41.86% |
0.10% |
医药生产-其他 |
5.60% |
154.91 |
-29.52% |
82.90 |
46.49% |
0.31% |
医药生产-清热解毒类 |
2.19% |
60.47 |
-9.55% |
38.46 |
36.40% |
0.92% |
医药生产-消化系统类 |
3.71% |
102.65 |
-- |
20.72 |
79.81% |
-- |
医药生产-心血管系统 |
27.14% |
750.27 |
21.44% |
247.19 |
67.05% |
3.33% |
医药生产-原料药类 |
4.12% |
113.84 |
14.50% |
66.95 |
41.19% |
-6.13% |
医药生产-止痛类 |
8.10% |
223.97 |
59.20% |
97.52 |
56.46% |
0.72% |
总计 |
2763.96 |
行业收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
其他(补充) |
3.01% |
83.20 |
77.62% |
54.89 |
34.03% |
-31.05% |
其他贸易 |
1.08% |
29.81 |
100.66% |
23.13 |
22.42% |
1.76% |
医药批发 |
11.33% |
313.20 |
-24.45% |
296.22 |
5.42% |
-1.71% |
医药生产 |
84.58% |
2337.74 |
9.95% |
702.88 |
69.93% |
0.30% |
总计 |
2763.96 |
地区收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
出口业务 |
0.30% |
8.38 |
-20.13% |
6.09 |
27.28% |
-5.65% |
东北地区 |
6.71% |
185.54 |
-5.68% |
71.16 |
61.65% |
-7.82% |
华北地区 |
31.33% |
865.99 |
-1.45% |
406.99 |
53.00% |
5.08% |
华东地区 |
18.64% |
515.16 |
5.82% |
190.34 |
63.05% |
4.82% |
华南地区 |
9.11% |
251.68 |
18.75% |
86.34 |
65.69% |
-0.96% |
华中地区 |
12.93% |
357.46 |
7.59% |
119.34 |
66.62% |
2.49% |
其他(补充) |
3.01% |
83.20 |
77.62% |
54.89 |
34.03% |
-31.05% |
西北地区 |
5.62% |
155.32 |
-8.10% |
47.71 |
69.28% |
0.17% |
西南地区 |
12.35% |
341.22 |
26.56% |
94.26 |
72.37% |
-0.81% |
总计 |
2763.96 |